These 2 'Buy Signals' Delivered Safe 7%+ Payouts, 90% Returns

 | Jan 17, 2023 04:43AM ET

As dividend investors, safe payouts are our No. 1 (and 2! and 3!) priority. And with interest rates soaring and a recession looming, we’re going to be bigger sticklers than ever about this in 2023.

That’s why, last week, we talked about five popular dividend stocks whose payouts could be slashed this year. If you hold any of these laggards, you need to sell them yesterday.

But how do we tell which dividends are safe?

Well, there’s a surefire indicator that no one talks about: insider buying. And when you combine insider buying with another “signal” we look for in stock, high short interest, you can set yourself up for safe, growing dividends and serious price gains, too!

Let’s start our “contrarian 2-step buying plan” with those corporate insiders, because their purchases are almost always a bullish sign for us.

h2 Only 2 Reasons Why Execs Buy/h2

There are lots of reasons why a corporate exec might sell their company’s stock: to put in a pool, send a kid to school, pay for a divorce—you get the idea. But there are only two reasons why they’d buy:

  1. Because they believe the current dividend is safe, and
  2. They think the stock price is going to go up.

That first point is never discussed when it comes to insider buys, but it should be. Because you can bet that if an executive is collecting a fat dividend from their stock and they buy more, they’re sure the company can keep that income stream rolling out.

This brings me to “boring” chemical maker Chemours Co. (CC), which we bought in our Contrarian Income advisory in June 2020, when it yielded an outsized 7.4%.

Then, as now, the macro picture was uncertain. I probably don’t have to remind you that in June of ’20, stocks were bouncing back from the March crash, but lockdowns were still crippling the economy (and planting the seeds for today’s high inflation).

Everyone was feeling twitchy about stocks (and dividends, many of which had just been chopped). The mood wasn’t a lot different than it is now.

This is where the short interest comes in, as short sellers were also betting big against Chemours as the company faced pending litigation. By June 2020, 10% of Chemours’ shares were sold short, and these early sellers even had to pay the company’s fat dividend out of their own pockets! (That’s a risk of short selling that you rarely hear about—and why the practice can be especially costly with dividend stocks.)

h2 CC Short Interest Spikes